• Chat
  • Dashboard
  • Daily Briefing
  • Discover
    • Feedback
    • Sign In
    Sign InSign Up

    Hims is in the crosshairs. Is a crackdown coming for compounding? - statnews.com

    AI Summary1 min read

    TL;DR

    Novo Nordisk is suing Hims & Hers for allegedly copying its Wegovy weight loss drugs, causing Hims' stock to drop significantly and forcing it to delay its own weight loss pill launch amid FDA scrutiny.

    Tags

    HimsNovo NordiskWegovypatent lawsuitweight loss drugs
    1. Hims is in the crosshairs. Is a crackdown coming for compounding?  statnews.com
    2. Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock falls 18%  CNBC
    3. Hims retreats from weight loss pill launch as Novo, FDA pressure mounts  Fierce Pharma
    4. Novo Nordisk opens new front with patent suit over Hims’ Wegovy copies  Reuters
    5. HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell?  Yahoo Finance

    Wednesday, February 11, 2026 9:37 AM

    Visit Website
    website-logo

    Top stories - Google News

    Google News

    channel icon
    Related Articles

    Trump orders Pentagon to buy coal power as the polluting fuel struggles to survive - The Washington Post

    Feb 12, 2026

    What We Know About the El Paso Airspace Shutdown - The New York Times

    Feb 12, 2026

    2026 Pac-12 football schedule announced - FBSchedules.com

    Feb 12, 2026

    ‘He’s got that farmer’s strength.’ Ben Ogden, and a silver medal long in the making. - The Washington Post

    Feb 12, 2026
    xgithub
    logo

    Copyright © 2022-2026 - Aetos.AI